Article
KRAS and aneusomy of chromosomes 4, 10 and 12 in colorectal carcinomas.
Pathology, research and practice - 1 Sept 2015
Beyer Kristin, Altendorf-Hofmann Annelore, Chen Yuan, Bickel Klaus, Petersen Iver
Abstract excerpt
AIMS: KRAS mutation status has predictive significance in EGFR-antibody treatment of colorectal adenocarcinoma. The aim of the study was the evaluation of KRAS mutation status in correlation to KRAS copy numbers and ploidy status. METHODS: Colorectal adenocarcinomas (n=52) were assembled into a TMA and analyzed by FISH. Probes for centromeres 4 and 10 were applied as surrogate markers for the ploidy status. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
